PTC Therapeutics to Participate at Upcoming Investor Conference

Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced its participation in the SVB Securities Global Biopharma Conference on February 14, 2023, at 9:20 a.m. EST. The company will present a comprehensive overview of its operations and strategic focus. A live webcast of the presentation will be available on PTC's Events and Presentations page and will be archived for 30 days. PTC is dedicated to developing innovative treatments for patients with rare disorders, aiming to maximize access to transformative medicines. For further details, visit www.ptcbio.com.

SOUTH PLAINFIELD, N.J., Feb. 2, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conference:

SVB Securities Global Biopharma Conference
Tuesday, Feb. 14 at 9:20 a.m. EST

The presentation will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conference-301737826.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics present at the SVB Securities Global Biopharma Conference?

PTC Therapeutics will present on February 14, 2023, at 9:20 a.m. EST.

How can I watch the PTC Therapeutics conference presentation?

The presentation can be viewed live on PTC's Events and Presentations page.

Will the PTC Therapeutics presentation be available after the event?

Yes, the presentation will be archived for 30 days following the event.

What is the focus of PTC Therapeutics as a biopharmaceutical company?

PTC Therapeutics focuses on discovering and commercializing medicines for patients with rare disorders.

What is the stock symbol for PTC Therapeutics?

The stock symbol for PTC Therapeutics is PTCT.